| abstract |
The invention relates to pharmaceutics and para-pharmaceutics, and more particularly to agents for the cessation of smoking. Proposed is a complex anti-nicotine agent, containing nicotine or a nicotine-like alkaloid and the amino acids theanine 50-200 mg and tryptophan 8-50 mg in 1 dose. The agent can be made available in the form of sweets, chewing gum, tablets, drops, syrups and transdermal systems. |